Recombinant Human APOC2 Protein, C-His

Description of Recombinant Human APOC2 Protein, C-His

Introduction to Recombinant Human APOC2 Protein

Recombinant Human APOC2 Protein, also known as Apolipoprotein C2, is a protein that plays a crucial role in lipid metabolism and is primarily found in the liver and intestine. It is a small globular protein with a molecular weight of 7.8 kDa and is composed of 79 amino acids. APOC2 is a member of the apolipoprotein family, which includes other important proteins such as APOE and APOA1.

Structure of Recombinant Human APOC2 Protein

The structure of Recombinant Human APOC2 Protein consists of a single polypeptide chain with a compact globular shape. It contains four alpha-helices, which are interconnected by three disulfide bridges. The protein also has a hydrophobic core, which is responsible for its stability. APOC2 has a high content of basic amino acids, which gives it a net positive charge at physiological pH. This feature allows the protein to interact with negatively charged lipids and play a crucial role in lipid metabolism.

Activity of Recombinant Human APOC2 Protein

Recombinant Human APOC2 Protein is an important regulator of lipid metabolism, particularly in the metabolism of triglyceride-rich lipoproteins (TRLs). It acts as a cofactor for lipoprotein lipase (LPL), an enzyme that breaks down triglycerides into free fatty acids and glycerol. APOC2 binds to LPL and helps in its activation, leading to the hydrolysis of triglycerides from circulating TRLs. This process is essential for the transport of lipids from the bloodstream to tissues for energy production or storage.

In addition to its role in lipid metabolism, APOC2 also plays a crucial role in the regulation of glucose metabolism. It has been found to enhance the uptake of glucose by adipose tissue and skeletal muscle, thereby contributing to the maintenance of glucose homeostasis. APOC2 also has anti-inflammatory properties and has been shown to inhibit the production of pro-inflammatory cytokines, making it a potential therapeutic target for inflammatory diseases.

Application of Recombinant Human APOC2 Protein

The primary application of Recombinant Human APOC2 Protein is in the study of lipid metabolism and its role in various diseases. Mutations in the APOC2 gene have been linked to familial chylomicronemia syndrome, a rare genetic disorder characterized by high levels of triglycerides in the blood. The use of recombinant APOC2 protein in in vitro and in vivo studies has helped in understanding the mechanism of this disorder and its potential treatment options.

Another potential application of recombinant APOC2 protein is in the development of therapeutics for dyslipidemia and other metabolic disorders. APOC2 deficiency has been associated with increased risk of atherosclerosis and cardiovascular diseases. By understanding the structure and function of APOC2, researchers can develop drugs that target this protein and modulate its activity, thereby regulating lipid metabolism and reducing the risk of cardiovascular diseases.

Furthermore, recombinant APOC2 protein has been used in the development of diagnostic tests for lipid disorders. Its ability to bind to LPL and regulate triglyceride metabolism makes it a potential biomarker for assessing the risk of cardiovascular diseases. By measuring the levels of APOC2 in the blood, clinicians can identify individuals with dyslipidemia and provide appropriate treatment options.

Conclusion

Recombinant Human APOC2 Protein is a small but important protein that plays a crucial role in lipid and glucose metabolism. Its structure and function have been extensively studied, and it has been found to have potential applications in the development of therapeutics and diagnostic tests for various metabolic disorders. Further research on APOC2 and